Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News What makes Qurient’s CDK7 inhibitor pairing with Synaffix’s exatecan payload a potential game changer? Synaffix and Qurient team up on a dual-payload ADC using exatecan and CDK7 inhibitor, aiming to reshape targeted cancer therapy and boost Lonza’s platform strategy. byPallavi MadhirajuSeptember 27, 2025